Advicenne S.A. (EPA:ALDVI)
1.512
-0.064 (-4.06%)
Sep 29, 2025, 2:39 PM CET
Advicenne Revenue
Advicenne had revenue of 3.50M EUR in the half year ending December 31, 2024, with 237.42% growth. This brings the company's revenue in the last twelve months to 5.90M, down -5.38% year-over-year. In the year 2024, Advicenne had annual revenue of 5.27M, down -0.51%.
Revenue (ttm)
5.90M
Revenue Growth
-5.38%
P/S Ratio
3.79
Revenue / Employee
453.54K
Employees
13
Market Cap
22.33M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.27M | -27.00K | -0.51% |
Dec 31, 2023 | 5.30M | 1.58M | 42.53% |
Dec 31, 2022 | 3.72M | -9.00K | -0.24% |
Dec 31, 2021 | 3.72M | 233.00K | 6.67% |
Dec 31, 2020 | 3.49M | 907.00K | 35.10% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 4.12B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
ABIVAX Société Anonyme | 6.02M |
Virbac | 1.43B |